HeadSense Secures Financing For Non-Invasive Neurological Monitor
HeadSense, an early stage company developing a non-invasive neurological
monitor focused initially on an intracranial pressure (ICP) application,
today announced it closed financing led by Pontifax, a leading Israeli
HeadSense, an early stage company developing a non-invasive neurological monitor focused initially on an intracranial pressure (ICP) application, today announced it closed financing led by Pontifax, a leading Israeli VC; GE Ventures of Menlo Park, California, USA; Everett Partners, an investment group based out of Akron, Ohio, USA; and JuMaJo, an investment group from Hamburg, Germany. HeadSense will use the investment to continue to expand its revolutionary work in bringing to market its non-invasive ICP monitor. HeadSense’s device includes an earbuds-like disposable unit that is placed in the patient’s ears. The device generates an acoustic signal that is circulated through the head and then is picked up in the other ear using an acoustic sensor. The data generated from the signal can then be analyzed in real-time from a tablet or smartphone. Guy Weinberg, CEO of HeadSense, said, “Intracranial pressure is an important parameter for the diagnosis and monitoring of patients suffering from head trauma, strokes and other conditions. The current gold-standard is expensive, invasive and requires a skilled neurosurgeon. With this new distributive technology we are offering a non-invasive, accurate, continuous and cost-effective alternative that will improve patient care by allowing more patients to be monitored with reduced costs.” Noah Lewis, managing director, GE Ventures, Healthcare said, “Disruptive digital and mobile health innovation, like HeadSense, is crucial to improving the quality and affordability of healthcare. We are excited to help HeadSense as it brings its technology to market.” Financial terms of the transaction were not disclosed. About Headsense: HeadSense Medical Ltd. is an early stage company, developing a non-invasive intracranial pressure (ICP) monitor. The company graduated from the Targetech Innovation Center in Netanya, Israel, and started its activity on April 2011. For more information: http://www.head-sense-med.com/homeAbout GE Ventures GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and healthcare, GE Ventures helps entrepreneurs and start-ups succeed by providing access to GE’s technical expertise, capital and opportunities for commercialization through GE’s global network of business, customers and partners. GE Ventures is headquartered in Menlo Park, CA. For more information, please visit http://www.ge.com/company/ge-ventures.